PharmaRoth Labs (PharmaRoth Labs) EBIT per Share : $-0.00 (TTM As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs EBIT per Share?

PharmaRoth Labs's EBIT per Share for the three months ended in Mar. 2011 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PharmaRoth Labs's EBIT per Share or its related term are showing as below:

ROTH's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

PharmaRoth Labs's EBIT for the three months ended in Mar. 2011 was $-0.10 Mil.

PharmaRoth Labs EBIT per Share Historical Data

The historical data trend for PharmaRoth Labs's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs EBIT per Share Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

EBIT per Share

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
EBIT per Share	Get a 7-Day Free Trial											-	-	-	-	-

PharmaRoth Labs EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PharmaRoth Labs's EBIT per Share for the fiscal year that ended in Jun. 2010 is calculated as

	EBIT per Share		(A: Jun. 2010 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.02	/	46.738
=	-0.00

PharmaRoth Labs's EBIT per Share for the quarter that ended in Mar. 2011 is calculated as

	EBIT per Share		(Q: Mar. 2011 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.098	/	137.768
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

PharmaRoth Labs (GREY:ROTH) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PharmaRoth Labs EBIT per Share Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022